Natural killer cell and T-cell crosstalk in CMV infection
Natural killer cell and T-cell crosstalk in CMV infection
批准号:
9398188
负责人:
KATHARINE C HSU
金额:
$30.63万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-02-15 至 2019-01-31
关键词:
Activated Natural Killer CellAdoptive TransferAffectAlpha CellAntigen-Presenting CellsAntigensAutologousBindingBiological AssayBlood specimenC57BL/6 MouseCD8-Positive T-LymphocytesCell CommunicationCell TransplantsCell physiologyCell surfaceCellsChronicCytomegalovirusCytomegalovirus InfectionsCytotoxic T-LymphocytesDataDendritic CellsDevelopmentEquilibriumGoalsHematopoieticHumanImmuneImmune responseImmune systemImmunocompromised HostIn VitroIncubatedIndividualInfectionInnate Immune SystemKineticsKnowledgeLymphocyteMaintenanceMediatingMemoryModelingMorbidity - disease rateMusNatural ImmunityNatural Killer CellsNewborn InfantOrganPDCD1LG1 genePatientsPeptidesPhenotypePhysiologic pulsePopulationRecoveryShapesSolidStem cell transplantSurfaceSystemT cell responseT-Cell ProliferationT-LymphocyteTransplant RecipientsTransplantationUp-RegulationViralVirusVirus Diseasescohortcomparativehematopoietic cell transplantationin vivoinhibiting antibodyinsightmortalitymouse modelnovelpathogenperipheral bloodpreventreconstitutionresponseseropositive
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Human cytomegalovirus (HCMV) is the most common cause of congenital viral infection and an
important cause of morbidity and mortality following solid organ and hematopoietic cell
transplantation. Understanding how the immune system responds to HCMV is vital to the efforts
to achieve efficient eradication of infection. This proposal aims to identify novel relationships
between NK cells and T cells during HCMV infection, with the central hypothesis that a strong T
cell response to HCMV infection can abrogate the emergence of an NK memory phenotype;
reciprocally, a HCMV-activated NK cell can regulate the magnitude of the T-cell response.
Using a unique fully autologous in vitro HCMV infection system, regulatory relationships
between NK cells and T cells can be investigated and identified. Preliminary studies have
generated the novel finding that direct interaction of NK cells with HCMV-infected dendritic cells
induces PD-L1 surface expression on NK cells, which directly inhibits antibody-mediated T cell
proliferation. To determine the impact of PDL1+ NK cell on HCMV antigen specific T cells, T cell
responses to HCMV infection will be stimulated by the use of an artificial antigen-presenting cell
pulsed with CMVpp65 peptides. Co-incubation of CMV-activated PDL1+ NK cells and CMV-
sensitized T cells will permit elucidation of regulatory effects of one lymphocyte on the other.
Additionally, preliminary data from an in vivo murine model has recapitulated findings in the
human studies, showing a significant increase in the number of PDL1+ NK cells following
MCMV infection of C57BL/6 mice. Using genetically novel murine systems, the in vivo impact of
PDL1+ NK cells on MCMV-specific T cell responses and the efficiency of viral clearance will be
determined. These murine models will allow for correlation of strength of the NK cell response
with CMV-specific T cell responses and will also provide insight to how this relationship is
controlled. The understanding of NK and T cell relationships developed in the in vitro and in
vivo studies will be applied to the study of expansion and maintenance of adaptive NKG2C+ NK
cells in healthy human donors as well as in patients with CMV reactivation following stem cell
transplantation. The availability of blood samples from a cohort of hematopoietic cell transplant
patients with CMV reactivation provides the unique opportunity to examine the NK and T cell
repertoire in the setting of CMV infection. These studies will describe novel mechanisms that will
expand existing knowledge on the balance of the adaptive and innate immune systems during
viral infection and will provide further insight to mechanisms that can be targeted to prevent
reactivation and chronic viral infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HCMV-induced innate-like CD8 T cells and allogeneic HCT outcome
-
批准号:10390447
-
项目类别:
-
资助金额:$70.98万
-
财政年份:2021
-
负责人:KATHARINE C HSU
-
依托单位:
Machine learning with immunogenetics for the prediction of hematopoietic cell transplant outcomes
-
批准号:10322105
-
项目类别:
-
资助金额:$60.84万
-
财政年份:2021
-
负责人:KATHARINE C HSU
-
依托单位:
HCMV-induced innate-like CD8 T cells and allogeneic HCT outcome
-
批准号:10590647
-
项目类别:
-
资助金额:$73.31万
-
财政年份:2021
-
负责人:KATHARINE C HSU
-
依托单位:
Machine learning with immunogenetics for the prediction of hematopoietic cell transplant outcomes
-
批准号:10534187
-
项目类别:
-
资助金额:$59.59万
-
财政年份:2021
-
负责人:KATHARINE C HSU
-
依托单位:
KIR and HLA in cis and trans cooperatively shape human NK education
-
批准号:9160652
-
项目类别:
-
资助金额:$42.85万
-
财政年份:2016
-
负责人:KATHARINE C HSU
-
依托单位:
KIR and HLA in cis and trans cooperatively shape human NK education
-
批准号:9310137
-
项目类别:
-
资助金额:$42.85万
-
财政年份:2016
-
负责人:KATHARINE C HSU
-
依托单位:
Phase I study humanized 3F8 MoAb (IND 112594) and NK cells (IND BB-13399) for neuroblastoma
-
批准号:9488351
-
项目类别:
-
资助金额:$24.99万
-
财政年份:2016
-
负责人:KATHARINE C HSU
-
依托单位:
Selection of Allogeneic Hematopoietic Cell Donor Based on KIR and HLA Genotypes
-
批准号:9271228
-
项目类别:
-
资助金额:$57.34万
-
财政年份:2015
-
负责人:KATHARINE C HSU
-
依托单位:
Selection of Allogeneic Hematopoietic Cell Donor Based on KIR and HLA Genotypes
-
批准号:8865414
-
项目类别:
-
资助金额:$42.1万
-
财政年份:2015
-
负责人:KATHARINE C HSU
-
依托单位:
Combination immunotherapy for neuroblastoma: model of innate tumor immunity
-
批准号:8508896
-
项目类别:
-
资助金额:$34.4万
-
财政年份:2012
-
负责人:KATHARINE C HSU
-
依托单位:
Phase 1 Study of Immunotherapy with NK Cells anti-GD2 for Neuroblastoma
-
批准号:8217684
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2012
-
负责人:KATHARINE C HSU
-
依托单位:
Phase 1 Study of Immunotherapy with NK Cells anti-GD2 for Neuroblastoma
-
批准号:8544192
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2012
-
负责人:KATHARINE C HSU
-
依托单位:
Phase 1 Study of Immunotherapy with NK Cells anti-GD2 for Neuroblastoma
-
批准号:8730476
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2012
-
负责人:KATHARINE C HSU
-
依托单位:
Combination immunotherapy for neuroblastoma: model of innate tumor immunity
-
批准号:8731836
-
项目类别:
-
资助金额:$35.49万
-
财政年份:2012
-
负责人:KATHARINE C HSU
-
依托单位:
Combination immunotherapy for neuroblastoma: model of innate tumor immunity
-
批准号:8373670
-
项目类别:
-
资助金额:$36.44万
-
财政年份:2012
-
负责人:KATHARINE C HSU
-
依托单位:
NK Tolerance and Hematopoietic Cell Transplantation
-
批准号:7743072
-
项目类别:
-
资助金额:$42.08万
-
财政年份:2007
-
负责人:KATHARINE C HSU
-
依托单位:
NK Tolerance and Hematopoietic Cell Transplantation
-
批准号:8197289
-
项目类别:
-
资助金额:$41.65万
-
财政年份:2007
-
负责人:KATHARINE C HSU
-
依托单位:
NK Tolerance and Hematopoietic Cell Transplantation
-
批准号:7383207
-
项目类别:
-
资助金额:$42.13万
-
财政年份:2007
-
负责人:KATHARINE C HSU
-
依托单位:
NK Tolerance and Hematopoietic Cell Transplantation
-
批准号:7536389
-
项目类别:
-
资助金额:$42.08万
-
财政年份:2007
-
负责人:KATHARINE C HSU
-
依托单位:
NK Receptors and Bone Marrow Transplant Outcome
-
批准号:6704624
-
项目类别:
-
资助金额:$12.91万
-
财政年份:2004
-
负责人:KATHARINE C HSU
-
依托单位:
海外基金